Introducing Evaris Pharma – Evolving from Perrigo Australia and Returning to Australian Ownership

Evaris Pharma, originally founded as Orion Laboratories, has been a trusted provider of high-quality pharmaceutical solutions for patients across Australia and New Zealand for over 40 years. Now back in Australian ownership, the company is poised for its next phase of growth.

With comprehensive end-to-end capabilities, including regulatory expertise, GMP manufacturing, advanced chemistry and analysis, in-licensing, contract manufacturing, and commercialisation, Evaris Pharma is well-positioned to expand its impact in the region and beyond.

Newly appointed CEO Steffan Crausaz emphasised the company’s strong foundation and ambitious future: “Evaris Pharma has built its success on high-quality manufacturing operations in Perth and a skilled, dedicated team. The recent carve-out of our Australia/New Zealand business from Perrigo marks a new chapter – one where Australian ownership fuels our renewed focus on growth. We are well-positioned to expand our contribution to patient care, strengthen our business, and positively shape the pharmaceutical landscape in the region.”

Acquired by Perrigo in 2010, Orion Laboratories today reintroduces itself as Evaris Pharma. The name ‘Evaris’ reflects its mission – combining ‘Eva’ (meaning life) and ‘Aris’ (meaning best), symbolising the company’s dedication to excellence, patient-centric care, and industry leadership.

With its deep expertise and renewed strategic direction, Evaris Pharma is ready to evolve medicines by driving innovation, expanding partnerships, and enhancing patient healthcare outcomes across Australia, New Zealand, and beyond.

Visit our new website to explore the more than 70 products we manufacture and market in Australia and New Zealand
www.evarispharma.com

Follow us on LinkedIn to watch us grow
https://www.linkedin.com/company/evarispharma

For more information contact
Steffan Crausaz, CEO, Evaris Pharma
steffan.crausaz@evarispharma.com